Could a forehead device stop seizures in veterans?

NCT ID NCT07220161

Ongoing Disease control Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a non-invasive forehead device called Cefaly, already approved for migraines, can reduce seizures in veterans with drug-resistant epilepsy. Twenty-four veterans will be split into two groups: one gets standard care plus the device, the other gets standard care alone, then they switch. Researchers will track seizure frequency and quality of life over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cefaly device (non-invasive trigeminal nerve stimulation)
What this could lead to: If it works, this could offer a non-invasive, drug-free option to reduce seizures in people with epilepsy that doesn't respond to medication.
What could go wrong: This is a small, early-stage trial with only 24 veterans. The device is FDA-approved for migraines, not epilepsy, so its effectiveness for seizures is unproven. Results may not apply to all epilepsy types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY (TREATMENT REFRACTORY) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY (TREATMENT REFRACTORY)

Contacts and locations

Locations

Debakey VA Medical Center

Houston, Texas, 77080, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.